Disc Medicine Announces Exclusive Licensing Agreement with Mabwell Therapeutics for Novel Anti-TMPRSS6 Monoclonal Antibodies to Modulate Iron Homeostasis
20th January 2023
Portfolio
This post references, or is about Disc Medicine. Find out more by clicking below